(Q43577652)

24 November 2017

title

Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9. (English)

1 reference

24 November 2017

1 reference

1 reference

A Van der Perren

1

1 reference

24 November 2017

J Toelen

2

1 reference

24 November 2017

M Carlon

3

1 reference

24 November 2017

C Van den Haute

4

1 reference

24 November 2017

F Coun

5

1 reference

24 November 2017

B Heeman

6

1 reference

24 November 2017

V Reumers

7

1 reference

24 November 2017

L H Vandenberghe

8

1 reference

24 November 2017

J M Wilson

9

1 reference

24 November 2017

Z Debyser

10

1 reference

24 November 2017

V Baekelandt

11

1 reference

24 November 2017

language of work or name

1 reference

17 February 2011

1 reference

24 November 2017

1 reference

24 November 2017

volume

18

1 reference

24 November 2017

issue

5

1 reference

24 November 2017

page(s)

517-527

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2010.179

24 November 2017

exact match

0 references

cites work

Molecular genetic pathways in Parkinson's disease: a review

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Parkinson's disease: from monogenic forms to genetic susceptibility factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Mendelian forms of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Genetics of Parkinson's disease and parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Molecular pathogenesis of Parkinson disease: insights from genetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein: a new primate model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

The parkin protein as a therapeutic target in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Genetic mouse models of parkinsonism: strengths and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

alpha-Synucleinopathy models and human neuropathology: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

In vivo gene delivery for development of mammalian models for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Viral vectors, animal models and new therapies for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Adeno-associated viral vector (AAV)-mediated gene transfer in the red nucleus of the adult rat brain: comparative analysis of the transduction properties of seven AAV serotypes and lentiviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Clades of Adeno-associated viruses are widely disseminated in human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraints.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Efficient serotype-dependent release of functional vector into the culture medium during adeno-associated virus manufacturing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Rapid, simple, and versatile manufacturing of recombinant adeno-associated viral vectors at scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Neuron-specific gene expression of synapsin I. Major role of a negative regulatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Time course of transgene expression after intrastriatal pseudotyped rAAV2/1, rAAV2/2, rAAV2/5, and rAAV2/8 transduction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Dual reporter comparative indexing of rAAV pseudotyped vectors in chimpanzee airway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

New recombinant serotypes of AAV vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Highly efficient multicistronic lentiviral vectors with peptide 2A sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Noninvasive monitoring of long-term lentiviral vector-mediated gene expression in rodent brain with bioluminescence imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Characterization of lentiviral vector-mediated gene transfer in adult mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Design-based stereology in neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

7 January 2021

The rotenone model of parkinsonism--the five years inspection.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

7 January 2021

Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

7 January 2021

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.179

7 January 2021

Identifiers

DOI

10.1038/GT.2010.179

1 reference

Dimensions Publication ID

24 November 2017

1052021232

0 references

1 reference